AAAAAA
Results:
1-15
|
Results: 15
Authors:
ODERGREN T
HJALTASON H
KAAKKOLA S
SOLDERS G
HANKO J
FEHLING C
MARTTILA RJ
LUNDH H
GEDIN S
WESTERGREN I
RICHARDSON A
DOTT C
COHEN H
Citation: T. Odergren et al., A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY TO INVESTIGATE THE DOSE EQUIVALENCE OF DYSPORT(R) AND BOTOX(R) IN THE TREATMENT OF CERVICAL DYSTONIA, Journal of Neurology, Neurosurgery and Psychiatry, 64(1), 1998, pp. 6-12
Authors:
KAAKKOLA S
Citation: S. Kaakkola, ENTACAPONE - A VIEWPOINT, CNS DRUGS, 8(1), 1997, pp. 89-90
Authors:
LYYTINEN J
KAAKKOLA S
AHTILA S
TUOMAINEN P
TERAVAINEN H
Citation: J. Lyytinen et al., SIMULTANEOUS MAO-B AND COMT INHIBITION IN L-DOPA-TREATED PATIENTS WITH PARKINSONS-DISEASE, Movement disorders, 12(4), 1997, pp. 497-505
Authors:
KAAKKOLA S
NISSINEN E
TERAVAINEN H
Citation: S. Kaakkola et al., DETERMINATION OF M-O-METHYLATED AND P-O-METHYLATED PRODUCTS OF LEVODOPA AND COMT ACTIVITY IN PARKINSONS-DISEASE, Journal of neurochemistry, 69, 1997, pp. 174-174
Authors:
AHTILA S
KAAKKOLA S
GORDIN A
KORPELA K
HEINAVAARA S
KARLSSON M
WIKBERG T
TUOMAINEN P
MANNISTO PT
Citation: S. Ahtila et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS, Clinical neuropharmacology, 18(1), 1995, pp. 46-57
Authors:
KARMA A
SEPPALA I
MIKKILA H
KAAKKOLA S
VILJANEN M
TARKKANEN A
Citation: A. Karma et al., DIAGNOSIS AND CLINICAL CHARACTERISTICS OF OCULAR LYME BORRELIOSIS - REPLY, American journal of ophthalmology, 120(2), 1995, pp. 263-264
Authors:
KARMA A
SEPPALA I
MIKKILA H
KAAKKOLA S
VILJANEN M
TARKKANEN A
Citation: A. Karma et al., DIAGNOSIS AND CLINICAL CHARACTERISTICS OF OCULAR LYME BORRELIOSIS, American journal of ophthalmology, 119(2), 1995, pp. 127-135
Authors:
KAAKKOLA S
PALO J
MALMBERG H
SULKAVA R
VIRTANEN I
Citation: S. Kaakkola et al., NEUROFILAMENT PROFILE IN OLFACTORY MUCOSA OF PATIENTS WITH A CLINICAL-DIAGNOSIS OF ALZHEIMERS-DISEASE, Virchows Archiv, 424(3), 1994, pp. 315-319
Authors:
KAAKKOLA S
GORDIN A
MANNISTO PT
Citation: S. Kaakkola et al., GENERAL-PROPERTIES AND CLINICAL POSSIBILITIES OF NEW SELECTIVE INHIBITORS OF CATECHOL O-METHYLTRANSFERASE, General pharmacology, 25(5), 1994, pp. 813-824
Authors:
TERAVAINEN H
KAAKKOLA S
GORDIN A
AHTILA S
RITA H
Citation: H. Teravainen et al., COMT INHIBITION WITH ENTACAPONE IN PARKINSON PATIENTS TREATED EITHER WITH SINEMET OR SINEMET CR, Neurology, 44(4), 1994, pp. 10000259-10000259
Authors:
KAAKKOLA S
TERAVAINEN H
AHTILA S
RITA H
GORDIN A
Citation: S. Kaakkola et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON CLINICAL DISABILITY AND LEVODOPA METABOLISM IN PARKINSONIAN-PATIENTS, Neurology, 44(1), 1994, pp. 77-80
Authors:
TORNWALL M
KAAKKOLA S
TUOMAINEN P
KASK A
MANNISTO PT
Citation: M. Tornwall et al., COMPARISON OF 2 NEW INHIBITORS OF CATECHOL O-METHYLATION ON STRIATAL DOPAMINE METABOLISM - A MICRODIALYSIS STUDY IN RATS, British Journal of Pharmacology, 112(1), 1994, pp. 13-18
Authors:
KAAKKOLA S
WURTMAN RJ
Citation: S. Kaakkola et Rj. Wurtman, EFFECTS OF 2 DIKETOPIPERAZINES, CYCLO (HIS-PRO) AND CYCLO (ASP-PHE), ON STRIATAL DOPAMINE - A MICRODIALYSIS STUDY, Brain research bulletin, 32(6), 1993, pp. 667-672
Authors:
KAAKKOLA S
TERAVAINEN H
AHTILA S
GORDIN A
Citation: S. Kaakkola et al., EFFECTS OF ENTACAPONE, A COMT INHIBITOR, ON L-DOPA METABOLISM IN PARKINSONS-DISEASE (PD), Neurology, 43(4), 1993, pp. 197-197
Authors:
KAAKKOLA S
TUOMAINEN P
MANNISTO PT
PALO J
Citation: S. Kaakkola et al., BIOGENIC-AMINE METABOLITES IN THE CSF OF PATIENTS WITH LATE-ONSET ANDALCOHOLIC ATAXIAS, Acta neurologica Scandinavica, 87(4), 1993, pp. 309-311
Risultati:
1-15
|